SCTB39-1

· Sinocelltech Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCTB39-1, covering 2025-07-04 to 2025-07-04. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of SCTB39-1 in Advanced Solid Tumours [Phase 1, Phase 2]